Technology
Contact
Applications
Intelligent Drug Indication Expansion, Target Discovery and Drug Combination mining works combining biomedical and clinical literature with electronic medical records, ontologies and biological relationship databases. Our core knowledge base is being built around oncology indications, and can be applied to any genetic-related disease, or gene target-directed drug. It can also incorporate adverse events and toxicology information.


SaaS Solution
The platform can be used out of the box as a Cloud-based SaaS solution, or an On-premise solution sitting inside your organisation on your data.


We have a leveraged R&D partnership model for strategic collaborations to generate Knowledge-bases for drug repositioning, drug combinations, target ID and biomarker discovery in the oncology space.
Applications
Intelligent Drug Indication Expansion, Target Discovery and Drug Combination mining works combining biomedical and clinical literature with electronic medical records, ontologies and biological relationship databases. Our core knowledge base is being built around oncology indications, and can be applied to any genetic-related disease, or gene target-directed drug. It can also incorporate adverse events and toxicology information.


The platform can be used out of the box as a Cloud-based SaaS solution, or an On-premise solution sitting inside your organisation on your data.
SaaS Solution
We have a leveraged R&D partnership model for strategic collaborations to generate Knowledge-bases for drug repositioning, drug combinations, target ID and biomarker discovery in the oncology space.
Applications
The platform can be used out of the box as a Cloud-based SaaS solution, or an On-premise solution sitting inside your organisation on your data.
SaaS Solution
Resources
About
Technology
Contact
The platform can be used out of the box as a Cloud-based SaaS solution, or an On-premise solution sitting inside your organisation on your data.


Intelligent Drug Indication Expansion, Target Discovery and Drug Combination mining works combining biomedical and clinical literature with electronic medical records, ontologies and biological relationship databases. Our core knowledge base is being built around oncology indications, and can be applied to any genetic-related disease, or gene target-directed drug. It can also incorporate adverse events and toxicology information.


Applications
We have a leveraged R&D partnership model for strategic collaborations to generate Knowledge-bases for drug repositioning, drug combinations, target ID and biomarker discovery in the oncology space.

Intelligent Drug Indication Expansion, Target Discovery and Drug Combination mining works combining biomedical and clinical literature with electronic medical records, ontologies and biological relationship databases. Our core knowledge base is being built around oncology indications, and can be applied to any genetic-related disease, or gene target-directed drug. It can also incorporate adverse events and toxicology information.